Search by Categories
- Insights
- Rare Disease
- Oncology
- Cell and Gene Therapy
- Medical Devices
- Consulting
- News & Analysis
- Therapeutic Areas
Our expertise in the industry
How is a Rare disease defined? Well, it depends on the geography in question, since there is no universal definition, even so, the definition revolves around the point of prevalence or incidence o...
As per DelveInsight, the Small cell lung cancer market size is expected to increase at a CAGR of 15.2% during the study period (2017–30) attributing to a rich pipeline, healthcare spending, improv...
Alnylam Pharmaceuticals has released the Phase III results of the clinical trial ILLUMINATE-A evaluating lumasiran for Primary Hyperoxaluria Type 1Primary Hyperoxaluria Type 1 (PH1) is a rare ...
The US FDA has voted down Nektar Therapeutics’ opioid painkiller NKTR-181, designed to treat lower back pain. The FDA’s Anesthetic and Analgesic Drug Products Advisory Committee and the D...
Amgen has announced to purchase 20.5% of the stake in Chinese-American drug company BeiGene.As per the deal signed, Amgen will develop and commercialize around two dozen of its on-market as w...
In layman’s language, Cluster headache is a headache disorder that occurs in cyclical patterns. The term cluster headache itself defines the condition that these attacks occur in groups, or “clust...
Merck decides to acquire Peloton Therapeutics, fortifying Oncology pipelineMerck is ready to buy Peloton Therapeutics for USD 1.1 million. The companies have entered into a definitive agreeme...
Roche's takes a step- forward to treat Huntington's diseaseA new drug co-developed by Roche and Ionis Pharmaceuticals can be a potential candidate to treat Huntington's disease. RG6042 which i...
AgomAb Therapeutics raises USD 23.5 million for its agomAbsA Belgian biotherapeutics company AgomAb Therapeutics which has been in a long run of making agonistic antibodies has secured USD 23....
Tetra, Shionogi sign USD 40 Million deal for Alzheimer’s disease and fragile X syndromeTetra Discovery Partners is collaborating with Shionogi to progress its PDE4-targeting drug in ...
A Learning Disability (LD) is a neurological condition resulting from genetic and neuro...
What is Gene Therapy and Is the Skin Suitable for Gene Therapy? Since its first discove...
Heart failure (HF), also referred to as Congestive Heart failure (CHF), is a condition ...
In advanced cancer patients, the most common site for the occurrence of metastasis is c...
Depression is a mental condition characterized by prolonged series of poor moods, loss ...
Hear from our subject-matter experts and in-house KOL’s on Pharma and Healthcare market trends.
